The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum

References

• Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094–7.
   PubMed Web of Science ®Google Scholar
• Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatr. 2003;74:1206–9.
   PubMed Web of Science ®Google Scholar
• Knopman DS, Petersen RC, Edland SD, Cha RH, Rocca WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62:506–8.
   PubMed Web of Science ®Google Scholar
• Mercy L, Hodges JR, Dawson K, Barker RA, Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology. 2008;71:1496–9.
   PubMed Web of Science ®Google Scholar
• Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.
   PubMed Web of Science ®Google Scholar
• Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, . Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126(Pt 9):2016–22.
   Google Scholar
• Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, . Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol. 2005;62:925–30.
   PubMed Web of Science ®Google Scholar
• Rosen HJ, Gorno-Tempini ML, Goldman WP, Perry RJ, Schuff N, Weiner M, . Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58:198–208.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, . Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006;129(Pt 6):1385–98.
   Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, . Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–77.
   Google Scholar
• Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA, . Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology. 2002;58:1801–8.
   PubMed Web of Science ®Google Scholar
• Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, . Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002;58:1608–15.
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, . Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.
   PubMed Web of Science ®Google Scholar
• Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):1996–2005.
   Google Scholar
• Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord. 2004;17:282–6.
   Google Scholar
• Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61:349–54.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, . Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65:397–403.
   PubMed Web of Science ®Google Scholar
• Vossel KA, Miller BL. New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol. 2008;21:708–16.
   PubMed Web of Science ®Google Scholar
• Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
   PubMed Web of Science ®Google Scholar
• Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry. 2007;78:629–31.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, . Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252–8.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, . The natural history of primary lateral sclerosis. Neurology. 2006;66: 647–53.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2007;(1):CD001447.
   Google Scholar
• Bak TH, Hodges JR. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? J Neurol. 2001;248:260–70.
   PubMed Web of Science ®Google Scholar
• Van Bogaert L. Les troubles mentaux dans la sclerose laterale amyotrophique. L'encephale. 1925;20:27–47.
   Google Scholar
• Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002; 59:1077–9.
   PubMed Web of Science ®Google Scholar
• Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134(Pt 9):2582–94.
   Google Scholar
• Neary D, Snowden JS, Mann DM, Northen B, Goulding PJ, Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatr. 1990;53:23–32.
   PubMed Web of Science ®Google Scholar
• Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:826–30.
   PubMed Web of Science ®Google Scholar
• Larner AJ. Delusion of pregnancy in frontotemporal lobar degeneration with motor neurone disease (FTLD/MND). Behav Neurol. 2008;19:199–200.
   Google Scholar
• Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord. 2008;25:206–11.
   PubMed Web of Science ®Google Scholar
• Ostberg P, Bogdanovic N. Semantic dementia with lower motor neuron disease showing FTLD-TDP type 3 pathology (sensu Mackenzie). Neuropathology. 2011;31:271–9.
   PubMed Web of Science ®Google Scholar
• Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, Okazaki H, . Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200–7.
   PubMed Web of Science ®Google Scholar
• Catani M, Piccirilli M, Geloso MC, Cherubini A, Finali G, Pelliccioli G, . Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord. 2004;17:21–8.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Knopman DS, Whitwell JL, Boeve BF, Parisi JE, Petersen RC, . Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology. 2005;65:645–7.
   PubMed Web of Science ®Google Scholar
• Hu WT, Seelaar H, Josephs KA, Knopman DS, Boeve BF, Sorenson EJ, . Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol. 2009;66:1359–64.
   PubMedGoogle Scholar
• Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 1996;61:450–5.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, . Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Goldstein LH, Al-Chalabi A, Pickering A, Morris RG, Passingham RE, . Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 1997;62:464–72.
   PubMed Web of Science ®Google Scholar
• Bak TH, Hodges JR. The effects of motor neurone disease on language: further evidence. Brain Lang. 2004;89:354–61.
   PubMed Web of Science ®Google Scholar
• Rakowicz WP, Hodges JR. Dementia and aphasia in motor neuron disease: an underrecognised association? J Neurol Neurosurg Psychiatr. 1998;65:881–9.
   PubMed Web of Science ®Google Scholar
• Tsuji-Akimoto S, Hamada S, Yabe I, Tamura I, Otsuki M, Kobashi S, . Writing errors as a result of frontal dysfunction in Japanese patients with amyotrophic lateral sclerosis. J Neurol. 2010;257: 2071–7.
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Koyama S, Ohno H, Ishihara K, Nagumo K, Kawamura M. Writing errors and anosognosia in amyotrophic lateral sclerosis with dementia. Behav Neurol. 2008;19:107–16.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol. 2007;64:530–4.
   PubMedGoogle Scholar
• Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:67–74.
   PubMed Web of Science ®Google Scholar
• Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12:45–51.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci. 1995;129 Suppl:44–6.
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, . Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85:81–9.
   PubMed Web of Science ®Google Scholar
• Kew JJ, Leigh PN, Playford ED, Passingham RE, Goldstein LH, Frackowiak RS, . Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain. 1993;116(Pt 3):655–80.
   Google Scholar
• Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology. 2005;64:1222–6.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology. 1999;53:1665–70.
   PubMed Web of Science ®Google Scholar
• Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VM-Y, Hatanpaa KJ, . Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114:5–22.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, . Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137–53.
   PubMed Web of Science ®Google Scholar
• McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, . Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58:1803–9.
   PubMed Web of Science ®Google Scholar
• Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett. 1988;93:197–203.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol. 2003;105:98–102.
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, . TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602–11.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995–1007.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, . Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205–8.
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, . Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208–11.
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Foti D, Woulfe J, Hurwitz TA. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain. 2008;131(Pt 5):1282–93.
   Google Scholar
• Roeber S, Mackenzie IRA, Kretzschmar HA, Neumann M. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol. 2008;116:147–57.
   PubMed Web of Science ®Google Scholar
• Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132(Pt 11):2922–31.
   Google Scholar
• Seelaar H, Klijnsma KY, de Koning I, van der Lugt A, Chiu WZ, Azmani A, . Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol. 2010;257:747–53.
   PubMed Web of Science ®Google Scholar
• Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, . FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120: 33–41.
   PubMed Web of Science ®Google Scholar
• Snowden JS, Hu Q, Rollinson S, Halliwell N, Robinson A, Davidson YS, . The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 2011;122:99–110.
   PubMed Web of Science ®Google Scholar
• Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, Terada S, . FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009;118:617–27.
   PubMed Web of Science ®Google Scholar
• Neumann M, Roeber S, Kretzschmar H, Rademakers R, Baker M, Mackenzie IRA. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009;118(Pt 11):2922–31.
   Google Scholar
• Mackenzie IRA, Munoz DG, Kusaka H, Yokota O, Ishihara K, Roeber S, . Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol. 2011;121:207–18.
   Google Scholar
• Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, . Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851–4.
   PubMed Web of Science ®Google Scholar
• Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, . TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol. 2007;61:435–45.
   PubMed Web of Science ®Google Scholar
• Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, . Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol. 2008;67:555–64.
   PubMed Web of Science ®Google Scholar
• Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, . Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 2007;1184:284–94.
   PubMed Web of Science ®Google Scholar
• Yokota O, Davidson Y, Arai T, Hasegawa M, Akiyama H, Ishizu H, . Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease. Acta Neuropathol. 2010;120:789–801.
   Google Scholar
• Geser F, Martinez-Lage M, Kwong LK, Lee VM-Y, Trojanowski JQ. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol. 2009;256:1205–14.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, . Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology. 2008;70(Pt 2):1850–7.
   Google Scholar
• Wilson AC, Dugger BN, Dickson DW, Wang D-S. TDP-43 in aging and Alzheimer's disease—a review. Int J Clin Exp Pathol. 2011;4:147–55.
   PubMedGoogle Scholar
• Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, Kurosawa M, . RNA-binding protein TLS is a major nuclear aggregate- interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J Biol Chem. 2008;283:6489–500.
   PubMed Web of Science ®Google Scholar
• Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res. 2010;66:131–3.
   PubMed Web of Science ®Google Scholar
• Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, . Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65:1817–9.
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Guerreiro R, Vandrovcova J, Uphill J, Reiman D, Beck J, . The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451–6.
   PubMed Web of Science ®Google Scholar
• Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, . Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71:1220–6.
   PubMed Web of Science ®Google Scholar
• Dion PA, Daoud H, Rouleau GA. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet. 2009;10: 769–82.
   PubMed Web of Science ®Google Scholar
• Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology. 1994;44:1872–7.
   PubMed Web of Science ®Google Scholar
• Fallis BA, Hardiman O. Aggregation of neurodegenerative disease in ALS kindreds. Amyotroph Lateral Scler. 2009;10:95–8.
   PubMed Web of Science ®Google Scholar
• Cruts M, Gijselinck I, Van Der Zee J, Engelborghs S, Wils H, Pirici D, . Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006; 442:920–4.
   PubMed Web of Science ®Google Scholar
• Baker M, Mackenzie IRA, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, . Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–9.
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, . Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393:702–5.
   PubMed Web of Science ®Google Scholar
• Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, . Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 1994;44:1878–84.
   PubMed Web of Science ®Google Scholar
• Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atarés B, . A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology. 2005;64:1578–85.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen KC, Forman MS, Rosen HJ, Alving LI, Goldman J, Feiger J, . 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol. 2004;61:398–406.
   PubMed Web of Science ®Google Scholar
• Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, . Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatr. 2007;78:754–6.
   PubMed Web of Science ®Google Scholar
• Sleegers K, Brouwers N, Maurer-Stroh S, van Es MA, Van Damme P, van Vught PWJ, . Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology. 2008;71:253–9.
   PubMed Web of Science ®Google Scholar
• Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, . Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005;37: 806–8.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, . CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet. 2008;17:313–22.
   Google Scholar
• Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, . ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology. 2006;67:1074–7.
   PubMed Web of Science ®Google Scholar
• Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, . Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One. 2010;5:e9872.
   PubMed Web of Science ®Google Scholar
• Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, . CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett. 2006;398:83–4.
   PubMed Web of Science ®Google Scholar
• Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, . Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377–81.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep. 2006;6:37–46.
   PubMed Web of Science ®Google Scholar
• Masè G, Ros S, Gemma A, Bonfigli L, Carraro N, Cazzato G, . ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci. 2001;191:11–18.
   PubMed Web of Science ®Google Scholar
• Wicks P, Abrahams S, Papps B, Al-Chalabi A, Shaw CE, Leigh PN, . SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2009;256:234–41.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.
   PubMed Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, . TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572–4.
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim H-J, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, . Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.
   PubMed Web of Science ®Google Scholar
• Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, . Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011;20:3207–12.
   PubMed Web of Science ®Google Scholar
• Van Langenhove T, van der Zee J, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts. Neurobiol Aging. 2011 Oct 27. [Epub ahead of print].
   Google Scholar
• Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, . ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet. 2006;38:411–3.
   PubMed Web of Science ®Google Scholar
• Nishimura AL, Mitne-Neto M, Silva HCA, Richieri-Costa A, Middleton S, Cascio D, . A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75:822–31.
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, . Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223–6.
   PubMed Web of Science ®Google Scholar
• Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, . Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211–5.
   PubMed Web of Science ®Google Scholar
• van Es MA, Diekstra FP, Veldink JH, Baas F, Bourque PR, Schelhaas HJ, . A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. Neurology. 2009;72:287–8.
   PubMed Web of Science ®Google Scholar
• Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, . Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2 - 21.3. Brain. 2006;129(Pt 4):868–76.
   Google Scholar
• Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, . A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006;66:839–44.
   PubMed Web of Science ®Google Scholar
• Le Ber I, Camuzat A, Berger E, Hannequin D, Laquerrière A, Golfier V, . Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology. 2009;72:1669–76.
   PubMed Web of Science ®Google Scholar
• Valdmanis PN, Dupre N, Bouchard J-P, Camu W, Salachas F, Meininger V, . Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch Neurol. 2007;64:240–5.
   PubMed Web of Science ®Google Scholar
• Luty AA, Kwok JBJ, Thompson EM, Blumbergs P, Brooks WS, Loy CT, . Pedigree with frontotemporal lobar degeneration—motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurol. 2008;8:32.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Engelborghs S, Maes G, Cuijt I, Peeters K, Mattheijssens M, . Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2010;67:606–16.
   PubMed Web of Science ®Google Scholar
• Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, Crook R, . Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry. 2011;82:196–203.
   PubMed Web of Science ®Google Scholar
• Pearson JP, Williams NM, Majounie E, Waite A, Stott J, Newsway V, . Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J Neurol. 2011;258:647–55.
   PubMed Web of Science ®Google Scholar
• Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, . Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010;9:986–94.
   PubMed Web of Science ®Google Scholar
• Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai S-L, Myllykangas L, . Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010;9:978–85.
   PubMed Web of Science ®Google Scholar
• van Es MA, Veldink JH, Saris CGJ, Blauw HM, van Vught PWJ, Birve A, . Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41:1083–7.
   PubMed Web of Science ®Google Scholar
• Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, Wang L-S, Graff-Radford NR, . Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42:234–9.
   PubMed Web of Science ®Google Scholar
• Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, . A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012;11:54–65.
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, . A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111–3.
   PubMed Web of Science ®Google Scholar
• Seelaar H, Schelhaas HJ, Azmani A, Küsters B, Rosso S, Majoor-Krakauer D, . TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations. Brain. 2007;130(Pt 5):1375–85.
   Google Scholar
• Snowden J, Neary D, Mann DMA. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007; 114:31–8.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol. 2009;118:349–58.
   PubMed Web of Science ®Google Scholar
• Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, . p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691–702.
   PubMed Web of Science ®Google Scholar
• Orru S, Manolakos E, Orru N, Kokotas H, Mascia V, Carcassi C, . High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172–8.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Moglia C, Restagno G, Ossola I, Brunetti M, . Amyotrophic lateral sclerosis-frontotemporal lobar dementia in 3 families with p.Ala382Thr TARDBP mutations. Arch Neurol. 2010;67:1002–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, . Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol. 2011;68:594–8.
   PubMedGoogle Scholar
• Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, . SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60.
   PubMed Web of Science ®Google Scholar
• Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P, . TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol. 2009;65:470–3.
   PubMed Web of Science ®Google Scholar
• Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S, . Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat. 2009;30:E974–83.
   PubMed Web of Science ®Google Scholar
• Borroni B, Archetti S, Del Bo R, Papetti A, Buratti E, Bonvicini C, . TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. Rejuvenation Res. 2010;13: 509–17.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, . TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 2009;24:1843–7.
   PubMed Web of Science ®Google Scholar
• Gallone S, Giordana MT, Scarpini E, Rainero I, Rubino E, Fenoglio P, . Absence of TARDBP gene mutations in an italian series of patients with frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2009;28:239–43.
   Google Scholar
• Gijselinck I, Sleegers K, Engelborghs S, Robberecht W, Martin J-J, Vandenberghe R, . Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS. Neurobiol Aging. 2009;30:1329–31.
   PubMed Web of Science ®Google Scholar
• Rollinson S, Snowden JS, Neary D, Morrison KE, Mann DMA, Pickering-Brown SM. TDP-43 gene analysis in frontotemporal lobar degeneration. Neurosci Lett. 2007;419:1–4.
   PubMed Web of Science ®Google Scholar
• Origone P, Caponnetto C, Bandettini Di Poggio M, Ghiglione E, Bellone E, Ferrandes G, . Enlarging clinical spectrum of FALS with TARDBP gene mutations: S393L variant in an Italian family showing phenotypic variability and relevance for genetic counselling. Amyotroph Lateral Scler. 2010;11:223–7.
   PubMed Web of Science ®Google Scholar
• Yokoseki A, Shiga A, Tan C-F, Tagawa A, Kaneko H, Koyama A, . TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol. 2008;63:538–42.
   PubMed Web of Science ®Google Scholar
• Cairns NJ, Perrin RJ, Schmidt RE, Gru A, Green KG, Carter D, . TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report. Neuropathol Appl Neurobiol. 2010;36:673–9.
   Google Scholar
• Tamaoka A, Arai M, Itokawa M, Arai T, Hasegawa M, Tsuchiya K, . TDP-43 M337V mutation in familial amyotrophic lateral sclerosis in Japan. Intern Med. 2010;49:331–4.
   Google Scholar
• Pamphlett R, Luquin N, McLean C, Jew SK, Adams L. TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathol Appl Neurobiol. 2009;35:222–5.
   Google Scholar
• Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, . TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–16.
   PubMed Web of Science ®Google Scholar
• Fushimi K, Long C, Jayaram N, Chen X, Li L, Wu JY. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell. 2011;2:141–9.
   PubMedGoogle Scholar
• Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, . ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841–57.
   PubMed Web of Science ®Google Scholar
• Kino Y, Washizu C, Aquilanti E, Okuno M, Kurosawa M, Yamada M, . Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res. 2011;39:2781–98.
   PubMed Web of Science ®Google Scholar
• Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, . FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry. 2010;81:639–45.
   PubMed Web of Science ®Google Scholar
• Groen EJN, van Es MA, van Vught PWJ, Spliet WGM, van Engelen-Lee J, de Visser M, . FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol. 2010;67:224–30.
   PubMed Web of Science ®Google Scholar
• Drepper C, Herrmann T, Wessig C, Beck M, Sendtner M. C-terminal FUS/TLS mutations in familial and sporadic ALS in Germany. Neurobiol Aging. 2009;32:548.e1–4.
   Google Scholar
• Rademakers R, Stewart H, Dejesus-Hernandez M, Krieger C, Graff-Radford N, Fabros M, . Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:170–6.
   PubMed Web of Science ®Google Scholar
• Corrado L, Del Bo R, Castellotti B, Ratti A, Cereda C, Penco S, . Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet. 2010;47:190–4.
   PubMed Web of Science ®Google Scholar
• Ticozzi N, Silani V, Leclerc AL, Keagle P, Gellera C, Ratti A, . Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology. 2009;73:1180–5.
   PubMed Web of Science ®Google Scholar
• Bäumer D, Hilton D, Paine SML, Turner MR, Lowe J, Talbot K, . Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010;75:611–8.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, . Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 2010;20:1069–76.
   PubMed Web of Science ®Google Scholar
• Yan J, Deng H-X, Siddique N, Fecto F, Chen W, Yang Y, . Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology. 2010;75:807–14.
   PubMed Web of Science ®Google Scholar
• Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ, Jr, . Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010;19:4160–75.
   PubMed Web of Science ®Google Scholar
• Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, . Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology. 2010;74:366–71.
   PubMed Web of Science ®Google Scholar
• Broustal O, Camuzat A, Guillot-Noël L, Guy N, Millecamps S, Deffond D, . FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J Alzheimers Dis. 2010;22:765–9.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Aoki M, Warita H, Kato M, Mizuno H, Shimakura N, . FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J Hum Genet. 2010;55:252–4.
   PubMed Web of Science ®Google Scholar
• Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, . Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2010;67:455–61.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Parisi JE, Petersen RC, Boeve BF, Jack CR, Jr, . Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur J Neurol. 2010;17:969–75.
   PubMed Web of Science ®Google Scholar
• Kimonis VE, Fulchiero E, Vesa J, Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta. 2008;1782:744–8.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Pirici D, Van Langenhove T, Engelborghs S, Vandenberghe R, Hoffmann M, . Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology. 2009;73:626–32.
   PubMed Web of Science ®Google Scholar
• Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, . Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857–64.
   PubMed Web of Science ®Google Scholar
• Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, . TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol. 2007;66:152–7.
   PubMed Web of Science ®Google Scholar
• Koppers M, van Blitterswijk MM, Vlam L, Rowicka PA, van Vught PW, Groen EJ, . VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33:837.e7–13.
   Google Scholar
• DeJesus-Hernandez M, Desaro P, Johnston A, Ross OA, Wszolek ZK, Ertekin-Taner N, . Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS. Neurology. 2011;77: 1102–3.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R, . TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain. 2011;134(Pt 3):808–15.
   Google Scholar
• Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, . TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011;76:467–74.
   PubMed Web of Science ®Google Scholar
• Cruchaga C, Graff C, Chiang HH, Wang J, Hinrichs AL, Spiegel N, . Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch Neurol. 2011;68:581–6.
   PubMedGoogle Scholar
• Rollinson S, Mead S, Snowden J, Richardson A, Rohrer J, Halliwell N, . Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. Neurobiol Aging. 2011;32:758.e1–7.
   PubMedGoogle Scholar
• van der Zee J, Van Broeckhoven C. TMEM106B a novel risk factor for frontotemporal lobar degeneration. J Mol Neurosci. 2011;45:516–21.
   Google Scholar
• Vass R, Ashbridge E, Geser F, Hu WT, Grossman M, Clay-Falcone D, . Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:373–80.
   Google Scholar
• Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL. The human disease network. Proc Natl Acad Sci USA. 2007;104: 8685–90.
   PubMed Web of Science ®Google Scholar